Riskpilot← Back to searchSign inGet full accessMedihossi Oy
OYDissolvedY-tunnus 2157292-1Muottikatu 15-A5Medical specialists activities · NACE 8622Est. 20071 employees
Revenue 2025
EUR 225K
EBITDA margin
24.0%
Equity ratio
97.1%
Financial strength
Net profit 2025
EUR 38K
1 employees
| Revenue | EUR 225K | — |
| EBITDA | EUR 54K | — |
| Net profit | EUR 38K | — |
| Total assets | EUR 453K | -1% |
| Equity | EUR 440K | +87933% |
| Employees | 1 | — |
Legal name
Medihossi Oy
Y-tunnus number
2157292-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
16. marraskuuta 2007
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveydenhuoltopalveluiden ja lääkärivastaanottopalveluiden myynti. Yhtiö voi harjoittaa sijoitustoimintaa, arvopaperikauppaa sekä asuntojen vuokraustoimintaa. Yhtiö voi omistaa kiinteistöjä.
Address
Muottikatu 15-A5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 247 | 237 | 274 | 0 | 225 |
| Staff expenses | −122 | −102 | −85 | −0 | −105 |
| EBITDA | 66 | 83 | 120 | 0 | 54 |
| Depreciation & amort. | −5 | −14 | −10 | −0 | −9 |
| EBIT | 61 | 70 | 110 | 0 | 45 |
| Net financials | −1 | 5 | −4 | 0 | 1 |
| Profit before tax | 60 | 75 | 105 | 0 | 48 |
| Tax | 12 | 15 | 22 | −0 | 9 |
| Net profit | 48 | 60 | 84 | 0 | 38 |
| Item | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 370 | 412 | 528 | 456 | 453 |
| Equity | 330 | 365 | 419 | 1 | 440 |
| Long-term debt | 26 | 17 | 65 | 1 | 2 |
| Short-term debt | 15 | 31 | 43 | 2 | 11 |
| Total debt | 41 | 48 | 109 | 3 | 13 |
EBITDA margin
24.0%
This company
15.8%
Market median
+52% vs market
20202025
Equity ratio
97.1%
This company
38.2%
Market median
+154% vs market
20202025
Return on equity
8.7%
This company
18.4%
Market median
-53% vs market
20202025
Net profit margin
17.0%
This company
8.1%
Market median
+110% vs market
20202025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20202025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
PK Audit | Audit | 2025 |
TK Deputy auditor | Deputy auditor | 2007 |
HK Deputy Member | Deputy Member | 2021 |
PO Chief Executive Officer | Chief Executive Officer | 2007 |
| Former (3) | ||
KM Deputy Member | Deputy Member | 2019 – 2021 |
AO Deputy Member | Deputy Member | 2007 – 2019 |
AK Audit | Audit | 2007 – 2025 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medihossi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pertti Kalevi Mäkelä | Audit | 0 companies |
| Katri Marjaana Salmivalli | Deputy Member | 0 companies |
| Anne Orvokki Mykkänen | Deputy Member | 0 companies |
| Timo Kalevi Packalén | Deputy auditor | 0 companies |
| Heidi Karoliina Ilvonen | Deputy Member | 0 companies |
| Anne Kaarina Terho | Audit | 0 companies |
| Pekka Olavi Hossi | Chief Executive Officer | 0 companies |